BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need.
26-30 September, 2014, ESMO 2014, Madrid, Spain
29-30 September, New Developments in Cancer Biologics, Robinson College, Cambridge, UK
7-8 October, Cell Based Assay & Screening Technologies, Dublin, Ireland
BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have two antibody therapeutics in development. Find out more »
Latest Share Price
BioInvent is currently running early-stage clinical trials with its products. Click here to find out more »